Beta2 receptors on myocardial cells in human ventricular myocardium
Authors:
- Michael R. BristowMBMichael R. Bristow
- Robert GinsburgRGRobert Ginsburg
- 1 April 1986
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (12) , F3-F6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacology and inotropic potential of forskolin in the human heart.Journal of Clinical Investigation, 1984
- Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]‐nitrendipine binding sitesBritish Journal of Pharmacology, 1984
- β‐Adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand bindingBritish Journal of Pharmacology, 1983
- Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.Circulation Research, 1983
- Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenolAmerican Heart Journal, 1983
- Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand bindingLife Sciences, 1983
- The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)Journal of Cardiovascular Pharmacology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- ( )[125Iodo]cyanopindolol, a new ligand for ?-adrenoceptors: Identification and quantitation of subclasses of ?-adrenoceptors in guinea pigNaunyn-Schmiedeberg's Archives of Pharmacology, 1981
- Pharmacological actions of a new β-adrenoceptor agonist, MJ-9184-1, in anaesthetized catsBritish Journal of Pharmacology, 1972